Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Wells Fargo Healthcare Conference Transcript

Sep 06, 2023 / 02:15PM GMT
Release Date Price: €70.5 (-2.08%)
Timothy Ian Daley
Wells Fargo Securities, LLC, Research Division - Associate Analyst

All right. Great. Thank you, everybody, for being here. This is Tim Daley, Life Science Tools, Diagnostics and Pharma Services Analyst here at Wells Fargo. Welcome to the Healthcare Conference 2023 here in Boston. I'm pleased to have Bio-Techne here with us. We've got Jim Hippel, CFO; and David Clair, Investor Relations here with us on the stage. And we have a bunch of questions for them, a lot of hot topics that currently are on top of mind as well as on top of other companies' minds. And I'll probably leave a little bit of time at the end for Q&A. But just to, I guess, kick it off with the hot topic du jour, any update for us on August? How are things trending versus July, month-to-month volatility has been all over the place depending on end market, geographical market, any changes specifically?

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

Honestly, really nothing, no changes to report on since kind of the view we shared at our last

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot